In August 2025, the Indian Ministry of Health and Family Welfare introduced new guidelines for the export of OTC medicinal products, emphasizing stricter quality control measures to align with international standards. This policy change aims to enhance the credibility of Indian pharmaceutical exports, including antiseptic products like Dettol.
In November 2025, the WHO updated its guidelines on hand hygiene, highlighting the importance of effective antiseptic products in preventing healthcare-associated infections. While Dettol is not specifically mentioned, the guidelines underscore the relevance of high-quality antiseptics in global health initiatives.
In January 2026, the EMA released a report on the safety and efficacy of antiseptic products, reaffirming the importance of compliance with established pharmacopoeia standards. This report serves as a reminder for manufacturers to ensure their products meet the necessary quality benchmarks.
In March 2026, the MHRA conducted inspections of several manufacturing facilities producing antiseptic products, including those exporting to the UK. The inspections aimed to verify GMP compliance and ensure product safety for consumers.
These developments reflect a global trend towards stricter regulatory oversight and quality assurance in the production and export of antiseptic products, impacting manufacturers and exporters of Dettol from India.
